20 articles
A 2025 review examines how methylene blue's nitric oxide inhibition can restore vascular tone in septic and vasoplegic shock patients.
New research reveals how 850nm infrared light exposure to the body enhances mitochondrial function and improves color perception.
New study reveals LED workspaces impair retinal function, but a 60W incandescent bulb reverses the damage in just 2 weeks.
The CLEAR Harmony trial tested bempedoic acid's safety in statin-intolerant patients with uncontrolled LDL and high cardiovascular risk.
Learn a simple smartphone trick to measure infrared light in your environment and why it matters for health optimization.
A landmark Phase 3 trial evaluates whether omecamtiv mecarbil, a cardiac myosin activator, reduces cardiovascular death in HFrEF patients.
Large study shows minocycline, an affordable antibiotic, significantly improved functional outcomes in stroke patients within 90 days.
Deleting GTPBP3 in endothelial cells blocks angiogenesis via mtROS overload — and a mitochondria-targeted antioxidant reverses the damage.
A new PET imaging metric identifies patients with normal scans who still face 41% higher cardiovascular event risk.
Dr. Seheult demonstrates a simple $22 filter that reveals hidden infrared light and explains its crucial role in mitochondrial health.
Small trial explores how amiloride improves oxygen delivery to heart muscle by enhancing potassium transport in red blood cells.
Scientists found that boosting ApoM levels helps clear harmful cholesterol deposits that cause age-related vision loss and heart problems.
A Phase 2 trial tests once-daily oral resmetirom (MGL-3196) against placebo to reduce LDL-C in patients with inherited high cholesterol.
Scientists identify GSDME as a master switch driving abdominal aortic aneurysms through vascular aging, opening new treatment paths.
Revolutionary nanobody drug targets two proteins simultaneously, achieving complete tumor elimination in preclinical studies.
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
New research reveals how PINK1-mediated mitophagy protects against heart failure by preventing inflammatory DNA release from damaged mitochondria.
New study shows infrared light passes through the chest and improves eye function even when eyes aren't directly exposed.
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
